Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Europe committee rejects MS treatment Movectro

September 24, 2010 Sales and Marketing Cladribine, Merck Serono Movectro

The Europe Medicines Agency has rejected Merck Serono’s new multiple sclerosis treatment Movectro, saying its benefits do not outweigh its …
News

Novartis sells bladder treatment rights to Warner Chilcott

September 24, 2010 Sales and Marketing Enablex, Novartis, Warner Chilcott

Novartis is to sell the US rights to market its overactive bladder treatment Enablex to Warner Chilcott. Novartis will receive …
News

Avandia withdrawn in Europe, but remains in US

September 24, 2010 Sales and Marketing Avandia, FDA, pharmacovigilance, safety

GSK’s diabetes drug Avandia is to be withdrawn from the market in Europe because of high levels of heart attack, …
News

FDA committee backs Pradaxa

September 23, 2010 Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …
News

New Commercial Realities – Part 2: Key stakeholders in the changing healthcare environment

September 23, 2010 Sales and Marketing Kinapse, White paper

Feature
White paper

Gilenya approved as new frontline MS treatment

September 22, 2010 Research and Development, Sales and Marketing Cladribine, FDA, Novartis, gilenya

Novartis’ new multiple sclerosis treatment Gilenya has been approved by the FDA, and is set to significantly alter the way …
News

Tesco to sell cut-price Viagra

September 21, 2010 Sales and Marketing Boots, Pfizer, Tesco, supermarket, viagra

Tesco has declared a price war in erectile dysfunction, announcing it will sell Viagra through its in-store pharmacies for less …
News

Medical, marketing & sales: making cross-functional working work

September 21, 2010 Research and Development, Sales and Marketing marketing, sales force effectiveness, sales representatives

A successful market access strategy requires the close collaboration of all functions within a pharmaceutical company. Most notably, the triumvirate …
Feature

FDA launches safety review of Actos

September 20, 2010 Sales and Marketing Actos, Takeda, diabetes

A new safety review of Takeda’s diabetes drug Actos has been launched by the FDA after a long-term study suggested …
News

Novartis hails longer-lasting COPD drug

September 20, 2010 Research and Development, Sales and Marketing COPD, Novartis, Onbrez Breezhaler

A phase III treatment for COPD has demonstrated superior results over GSK’s established Serevent (salmeterol). Data from Novartis’ INSIST study …
News

Realising outsourcing’s potential

September 20, 2010 Sales and Marketing Kinapse, White paper

IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Feature
White paper

Digital Pharma: Novo launches insulin dosing app

September 17, 2010 Medical Communications, Sales and Marketing Digital Pharma blog, Novo Nordisk, app, diabetes, iphone

Novo Nordisk has launched an iPhone app for US healthcare professionals that enables to them look up dosing guidelines for …
News

J&J to acquire Crucell for $2.3 billion

September 17, 2010 Sales and Marketing Crucell, Johnson & Johnson

Johnson & Johnson is set to buy out Crucell for around $2.3 billion (1.75 bn euros) expanding its presence in …
News

MSD’s Dan Heapy joins MSI

September 16, 2010 Sales and Marketing MSI, appointment, sales and marketing

The MSI Consultancy has appointed Dan Heapy as a consultant. He joins MSI from MSD, where over five years he …
Appointment

AstraZeneca’s Brilinta delayed

September 16, 2010 Sales and Marketing Brillinta, Effient, Plavix, clopidogrel

AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026